fda ruling on tirzepatide update 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these is tirzepatide fda approved for

Patients using the highest dose lost up to 20.9% of their body weight over 72 weeksmore than many other FDA-approved weight loss medications

Tirzepatide demonstrated superior efficacy compared to placebo and other common glucose-lowering therapies, including semaglutide 1 mg, dulaglutide, insulin degludec, and glargine

Mycotoxins Mycotoxins: Assess your risk of mold exposure and mycotoxin accumulation with our Mycotoxins panel

We offer a Vitamin B12 injection which can be administered as a course of treatments or a top up treatment

Online services often do not provide this support

Presented for research literature review only Wagner J et al